Learn more

CYTOVIA INC

Overview
  • Total Patents
    205
About

CYTOVIA INC has a total of 205 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CEPHALON INC, INST PHARM & TOXICOLOGY AMMS and ASAHI KASEI PHARMA CORP.

Patent filings per year

Chart showing CYTOVIA INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Cai Sui Xiong 161
#2 Drewe John A 98
#3 Zhang Han-Zhong 71
#4 Kasibhatla Shailaja 54
#5 Weber Eckard 48
#6 Wang Yan 37
#7 Kemnitzer William E 29
#8 Green Douglas R 27
#9 Zhang Hong 26
#10 Mills Gordon B 24

Latest patents

Publication Filing date Title
WO2010008558A1 Compounds and methods of inducing apoptosis via interaction with chaperonin cct
WO2008057402A2 N-aryl-isoxazolopyrimidin-4-amines and related compounds as activators of caspases and inducers of apoptosis and the use thereof
CA2657931A1 3-aryl-6-aryl-7h-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and analogs as activators of caspases and inducers of apoptosis and the use thereof
CA2656706A1 Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof
US2007244114A1 Compounds and therapeutical use thereof
US2007213305A1 N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US2007099877A1 N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
CA2592900A1 Nitrogen containing bicyclic compounds and therapeutical use thereof
AU2006204052A1 Method of treating brain cancer
AU2005294430A1 Substituted N-aryl-1H-pyrazolo[3,4-b]quinolin-4-amines and analogs as activators of caspases and inducers of apoptosis
US2008096848A1 Substituted N-Aryl-9-Oxo-9H-Fluorene-1-Carboxamides and Analogs as Activators of Caspases and Inducers of Apoptosis
US2007093456A1 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis
AU2004253967A1 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
CN1784239A Protease inhibitors for coronaviruses and SARS-COV and the use thereof
CA2524882A1 Protease inhibitors for coronaviruses and sars-cov and the use thereof
CA2522700A1 Methods of treating diseases responsive to induction of apoptosis and screening assays
WO2004058253A1 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
AU2003300883A1 Substituted 1-benzoyl-3-cyano-pyrrolo(1,2-a)quinolines
CN1738620A Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis
AU2003241482A8 Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof